Dept. of Pediatrics, University of Florida, Gainesville, FL 32610, USA.
Adv Drug Deliv Rev. 2013 Jun 15;65(6):759-73. doi: 10.1016/j.addr.2012.10.013. Epub 2012 Nov 2.
Oral tolerance is defined as the specific suppression of humoral and/or cellular immune responses to an antigen by administration of the same antigen through the oral route. Due to its absence of toxicity, easy administration, and antigen specificity, oral tolerance is a very attractive approach to prevent unwanted immune responses that cause a variety of diseases or that complicate treatment of a disease. Many researchers have induced oral tolerance to efficiently treat autoimmune and inflammatory diseases in different animal models. However, clinical trials yielded limited success. Thus, understanding the mechanisms of oral tolerance induction to therapeutic proteins is critical for paving the way for clinical development of oral tolerance protocols. This review will summarize progress on understanding the major underlying tolerance mechanisms and contributors, including antigen presenting cells, regulatory T cells, cytokines, and signaling pathways. Potential applications, examples for therapeutic proteins and disease targets, and recent developments in delivery methods are discussed.
口服耐受是指通过口服途径给予相同抗原来特异性抑制对该抗原的体液和/或细胞免疫应答。由于其无毒性、易于管理和抗原特异性,口服耐受是一种非常有吸引力的方法,可以预防引起各种疾病或使疾病治疗复杂化的不需要的免疫反应。许多研究人员已经在不同的动物模型中诱导了口服耐受,以有效地治疗自身免疫和炎症性疾病。然而,临床试验的结果有限。因此,了解诱导口服耐受治疗性蛋白的机制对于为口服耐受方案的临床开发铺平道路至关重要。本文综述了在理解主要潜在耐受机制和贡献因素方面的进展,包括抗原呈递细胞、调节性 T 细胞、细胞因子和信号通路。讨论了潜在的应用、治疗性蛋白和疾病靶点的例子以及最近的递药方法的发展。